Health Condition 1: M479- Spondylosis, unspecified
Conditions
Interventions
Intervention1: Koduveli nei and Varmam therapy: Koduveli Nei will be given internally foe 9 days.
3 days of drug holiday
followed by it 15 days Varmam therapy
Control Intervention1: Varmam therapy: Va
Sponsors
National Institute of Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Patients having two or more clinical symptoms I.Pain in the lumbar region and pain increased in forward bending II.Radiating pain to buttocks and lower limbs III.Stiffness in the lumbar region IV.Increase in the pain on movements V.Numbness (Tingling sensation) in the lower limbs Grade I & II in the radiological findings of lumbar spine Patient who are willing to involve in the study by signing the consent and fulfilling the condition of performa, who are willing to undergo radiological and blood investigations. Patient who has Oswestry low back disability questionnaire total score 5-34
Exclusion criteria
Exclusion criteria: K/C/O Cardiovascular disease. K/C/O Autoimmune disease K/C/O spinal deformities K/C/O of renal diseases K/C/O Tuberculosis and other infections in the spine H/O Acute trauma/fracture Pregnancy and lactating mothers Patients with any other serious systemic illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The treatment is considered as effective by the reduction of 9 points in the score measured using Oswestry Lowback Disability Scale.Timepoint: | — |
Secondary
| Measure | Time frame |
|---|---|
| To estimate the effectiveness of drug and Varmam therapy in reducing the clinical symptoms in groups 1 and 2 compared with Standard control (Group 3) The adverse reactions will be noted in the Adverse Drug reaction form and reported to the Pharmacovigilance wing in the hospital. Timepoint: | — |
Countries
India
Contacts
Public ContactDr M V Mahadevan
National Institute of Siddha
Outcome results
None listed